Dose Increase of S-Adenosyl-Methionine and Escitalopram in a Randomized Clinical Trial for Major Depressive Disorder

BACKGROUND: The optimal dose of S-adenosyl methionine (SAMe) for major depressive disorder (MDD) remains unclear. The objective of this analysis was to address whether a dose increase provided further improvement in cases of insufficient response using data from an existing randomized clinical trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Affect Disord
Main Authors: Sakurai, Hitoshi, Carpenter, Linda, Tyrka, Audrey, Price, Lawrence H., Papakostas, George, Dording, Christina M, Yeung, Albert S, Cusin, Cristina, Ludington, Elizabeth, Bernard-Negron, Richard, Fava, Maurizio, Mischoulon, David
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917851/
https://ncbi.nlm.nih.gov/pubmed/31733455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2019.10.040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados